Vaccinations are a “no brainer” according to a cardiologist in the wake of the four viruses spreading like wildfire throughout the country. As the ‘quad-demic’ of Covid, flu, respiratory syncytial …
The NHS is urgently appealing for people with certain health conditions to get vaccinated against flu this winter. The health service has launched a drive to protect against a ‘tripledemic’ …
Routine COVID-19 vaccinations, mainly for people age 65 or older, began in Japan on Tuesday in a program running until March 31 next year. Available in the program are five …
As summer fades and a new school term begins, parents often brace themselves for the inevitable wave of germs that children bring home from school. The transition back to the …
Fall is nearly here, and that means it’s time to schedule the vaccinations that will help bolster your immune system and better protect yourself against some of the most popular …
Traders work on the floor of the New York Stock Exchange during morning trading on August 12, 2024 in New York City. Michael M. Santiago | Getty Images News | …
:quality(85):upscale()/2022/08/02/709/n/1922729/f5c8a24462e94a73617720.94608701_.jpg "Mpox Vaccine: Eligibility and Where to Get It")
Big news in the world of infectious disease: Mpox is back. The World Health Organization (WHO) has declared the recent spread a global health emergency as cases have been surging …
:quality(85):upscale()/2024/08/09/744/n/49351082/c2afd27166b6493e0ada50.87476015_.jpg "What to Know About the Breast Cancer Vaccine")
The earliest depiction of breast cancer dates back to 3500 BCE and while there have been plenty of advancements in detection (like AI mammography), treatment, and risk assessment — one …
Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter — and Wall Street took notice, CEO Albert Bourla told thousands of employees during a companywide …
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The Food and Drug Administration on Friday expanded the approval of GSK‘s respiratory syncytial virus …